| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MPS-1-IN-1 | GDSC1000 | pan-cancer | AAC | 0.0058 | 0.9 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.0062 | 0.9 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0063 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0069 | 0.9 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | -0.0079 | 0.9 |
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | -0.0062 | 0.9 |
| mRNA | staurosporine | CTRPv2 | pan-cancer | AAC | 0.013 | 0.9 |
| mRNA | LFM-A13 | GDSC1000 | pan-cancer | AAC | 0.0059 | 0.9 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | -0.0064 | 0.9 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |